Disease Diagnostic Techniques Of Contemporary Times In Nigeria
Volume 1 - Issue 5, November 2017 Edition
[Download Full Paper]
Author(s)
Victor. N Enwemiwe, Clement. C Obi, Kolade S, Fasoore
Keywords
diagnosis techniques, contemporary times, and Nigeria
Abstract
Diagnosis of parasitic diseases are globally important requisite to realization of wholesome treatment of ailment and reduction in resultant morbidities and mortalities. Parasitic diseases are however hyper- and hypo-prevalent in Nigerian populace often due to socio-economics factors and ranges of little or no sequels. Low mortality from parasitic infection is due to alternative medication other than successful diagnosis as observed. Subsidizing cost of affording diagnosis, erection of government owned diagnostic facilities or mobile diagnostic facilities and enlightening the general public on needs of diagnosis are key factors to adequate treatment, disease deterrence and control of parasitic diseases. This review presents the qualities and drawbacks in parasitic disease diagnosis in Nigeria, pointing out major disease occurrences and diagnosis techniques used in medical facilities as related globally. Thus, contemporary diagnostic techniques available for prompt, accurate and easy presentation of results on pathobiology of disease patterns including immunoassays, conservative and molecular techniques for different biopsy from zoonotic and human parasitic infections. However psychological limitation in Nigeria such as affordability, variability in confirming results from other diagnostic areas, and adequate staffing, can be conquered by training personnel annually on the use of the available tools.
References
[1] Akande T.M. and Monehin J.O., “Health management information system in private clinics in Ilorin, Nigeria,†Nig Med Pract 46(8), Pp 102–7. 2004.
[2] Bogitsh J. B. and Chang, C. T. J. Human Parasitology, Academic Press, London. 1998.
[3] Burbelo P. D., Goldman R., and Mattson T. L., “A simplified immunoprecipitation method for quantitatively measuring antibody responses in clinical sera samples by using mammalian-produced Renilla luciferase-antigen fusion proteins,†BMC Biotechnology 5(22). 2005.
[4] Burbelo P. D., Ramanathan R., Klion A. D., Iadarola M. J., and Nutman T. B., “Rapid, novel, specific, high-throughput assay for diagnosis of Loa loa infection†Journal of Clinical Microbiology 46(7), Pp 2298–2304. 2008.
[5] Campbell G. H., Aley S. B., Ballou W. R., “Use of synthetic and recombinant peptides in the study of host-parasite interactions in the malarias†American Journal of Tropical Medicine and Hygiene 37(3), Pp 428–444. 1987
[6] Carter W. J., Yan Z., Cassai N. D., and Sidhu G. S., “Detection of extracellular forms of babesia in the blood by electron microscopy: A diagnostic method for differentiation from Plasmodium falciparum,†Ultrastructural Pathology 27(4), Pp 211–216. 2003.
[7] Chappuis F., Rijal S., Soto A., Menten J., and Boelaert M., “A meta-analysis of the diagnostic performance of the direct agglutination test and rK39 dipstick for visceral leishmaniasis,†British Medical Journal 333(9), Pp 723–726. 2006.
[8] Cobo F., Aliaga L., Talavera P., and Concha A. “The histological spectrum of non-granulomatous localized mucosal leishmaniasis caused by Leishmania infantum,†Annals of Tropical Medicine and Parasitology 101(8), Pp 689–694. 2007.
[9] Courtioux B., Bisser S., and M'Belesso P., “Dot enzyme-linked immunosorbent assay for more reliable staging of patients with human African trypanosomiasis,†Journal of Clinical Microbiology 43(9), Pp 4789–4795. 2005.
[10] Cox, F. E. G. “History of human Parasitology,†Clinical Microbiological Reviews. 15 (4), Pp595-612. 2002.
[11] Croft A. M., Jackson C. J., Friend H. M., and E. J. Minton. “African trypanosomiasis in a British soldier,†Journal of the Royal Army Medical Corps 152(3), Pp 156–160. 2006
[12] Diez M., Favaloro L., and Bertolotti A., “Usefulness of PCR strategies for early diagnosis of Chagas†Disease reactivation and treatment follow-up in heart transplantation,†American Journal of Transplantation 7(6), Pp 1633–1640. 2007.
[13] Healy G. R. and Ruebush T. K., “Morphology of Babesia microti in human blood smears†American Journal of Clinical Pathology 73(1), Pp 107–109. 1980.
[14] Ko R. C. and Ng T. F., “Evaluation of excretory/secretory products of larval Taenia solium as diagnostic antigens for porcine and human cysticercosis,†Journal of Helminthology 72(2), Pp 147–154. 1998.
[15] Kumar N., Ghosh S., and Gupta S. C., “Early detection of Fasciola gigantica infection in buffaloes by enzyme-linked immunosorbent assay and dot enzyme-linked immunosorbent assay,†Parasitology Research 103(1), Pp 141–150. 2008.
[16] Muldrew K. L., “Molecular diagnostics of infectious diseases,†Current Opinion in Pediatrics 21(1), Pp 102–111. 2009.
[17] National Bureau of statistics. J Pharm Bioallied Sci. Oct-Dec; 3(4), Pp 470–478. 2011.
[18] Ndao “Diagnosis of parasitic diseases: old and new approaches†Hindawi Publishing Corporation Interdisciplinary Perspectives on Infectious Diseases Pp 1-15. 2009.
[19] Omoruan AI, Bamidele AP, and Phillips O.F. “Social health insurance and sustainable healthcare reform in Nigeria,†Ethno Med. 3: 105–10. 2009.
[20] Onwujekwe O, Onoka C, Uguru N, Nnenna T, Uzochukwu B, and Eze S,. “Preferences for benefit packages for community-based health insurance: An exploratory study in Nigeria. BMC Health Services Research 10, P 162. 2010.
[21] Pappas M. G. “Recent applications of the Dot-ELISA in immunoparasitology,†Veterinary Parasitology 29(2-3), Pp 105–129. 1988
[22] Pappas M. G., Hajkowski R., and Hockmeyer W. T., “Dot enzyme-linked immunosorbent assay (Dot-ELISA): a micro technique for the rapid diagnosis of visceral leishmaniasis,†Journal of Immunological Methods 64(1-2), Pp 205–214. 1983.
[23] Parida M. M., Sannarangaiah S., Dash P. K., Rao P. V. L., and Morita K., “Loop mediated isothermal amplification (LAMP): A new generation of innovative gene amplification technique; perspectives in clinical diagnosis of infectious diseases,†Reviews in Medical Virology 18(6) Pp 407–421. 2008.
[24] Shokoples S. E., Ndao M., Kowalewska-Grochowska K., and Yanow S. K., “Multiplexed real-time PCR assay for discrimination of Plasmodium species with improved sensitivity for mixed infections,†Journal of Clinical Microbiology 47(4) Pp 975–980. 2009.
[25] Steinberger R, Fuart F, van der Goot E, Best C, von Etter P, and Yangarber R. “Medical intelligence. In: Mining Massive Data Sets for Security. Amsterdam, the Netherlands: OIS Press. 2008.
[26] Tait B. D., Hudson F., and Cantwell L., “Review article: Luminex technology for HLA antibody detection in organ transplantation,†Nephrology 14(2), Pp 247–254. 2009.
[27] Tanowitz H. B., Kirchhoff L. V., Simon D., Morris S. A., Weiss L. M., and Wittner M., “Chagas' disease†Clinical Microbiology Reviews 5(4), Pp 400–419. 1992.
[28] WHO “Intestinal parasiteinfectionand urbanization,†WHO Bulletin 71, Pp 1-4. 1993.
[29] WHO. “Report on scientific working group on malaria,†TDR/SWG/03. 2003.
